Analgesic effects of huwentoxin-IV on animal models of inflammatory and neuropathic pain

Protein and Peptide Letters

Volumn 21, Issue 2, 2014, Pages 153-158

  Liu, Yu ^a   Wu, Zhe ^a   Tang, Dongfang ^a   Xun, Xiaohong ^a   Liu, Lichao ^a   Li, Xianlei ^a   Nie, Dongsong ^a   Xiang, Yang ^a   Yii, Jianming ^a   Yi, Jizu ^a  

^a HUNAN INSTITUTE OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Analgesic; Huwentoxin IV; Inflammatory pain; Neuropathic pain; Neurotoxin

Indexed keywords

ACETIC ACID; ANALGESIC AGENT; HUWENTOXIN 4; MEXILETINE; MORPHINE; UNCLASSIFIED DRUG;

ADULT; ALLODYNIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; ARTICLE; CHRONIC PAIN; CONTROLLED STUDY; DRUG EFFECT; EFFICIENCY EQUIVALENT; EXPERIMENTAL MODEL; FEMALE; HYPERALGESIA; INFLAMMATORY PAIN; MALE; MOUSE; NEUROPATHIC PAIN; NONHUMAN; PAIN ASSESSMENT; PAIN PARAMETERS; RAT; WRITHING TEST;

ACETIC ACID; ANALGESICS; ANIMALS; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; FORMALDEHYDE; INFLAMMATION; MICE; NEURALGIA; RATS; SPIDER VENOMS;

EID: 84893318577     PISSN: 09298665     EISSN: None     Source Type: Journal    
DOI: 10.2174/09298665113206660119     Document Type: Article

References (29)

1. Peng, K.; Shu, Q.; Liu, Z.H.; Liang, S.P. Function and Solution Structure of Huwentoxin-IV, a Potent Neuronal Tetrodotoxin (TTX)-sensitive Sodium Channel Antagonist from Chinese Bird Spider Selenocosmia huwena. J. Biol. Chem., 2002, 277, 47564-47571.
2. Zhu, Q.; Liang, S.P.; Martin, L.; Gasparini, S.; Ménez, A.; Vita, C. Role of disulfide bonds in folding and activity of leiurotoxin I: just two disulfides suffice. Biochemistry, 2002, 41, 11488-11494.
3. Xiao, Y.C.; Bingham, J.P.; Zhu, W.; Moczydlowski, E.; Liang, S.P.; Cummins, T.R. Tarantula huwentoxin-IV inhibits neuronal sodium channels by binding to receptor site 4 and trapping the domain ii voltage sensor in the closed configuration. J. Biol. Chem., 2008, 283, 27300-27313.
4. + channel voltage sensors in domains II and IV. J. Biol. Chem., 2011, 28, 27301-27310.
5. Catterall, W.A.; Goldin, A.L.; Waxman, S.G. International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltagegated sodium channels. Pharmacol. Rev., 2005, 57, 397-409.
6. Cummins, T.R.; Rush, A.M. Voltage-gated sodium channel block-ers for the treatment of neuropathic pain. Expert. Rev. Neurother., 2007, 7, 1597-1612.
7. Dib-Hajj, S.D.; Black, J.A.; Waxman, S.G. Voltage-gated sodium channels: therapeutic targets for pain. Pain. Med., 2009, 10, 1260-1269.
8. McGowan, E.; Hoyt, S.B.; Li, X.; Lyons, K.A.; Abbadie, C. A peripherally acting Nav1.7 sodium channel blocker reverses hyper-algesia and allodynia on rat models of inflammatory and neuropathic pain. Anesth. Analg., 2009, 109, 951-958.
9. Billen, B.; Bosmans, F.; Tytgat, J. Animal peptides targeting volt-age-activated sodium channels. Curr. Pharm. Des., 2008, 14, 2492-2502.
10. Wood, J.N.; Boorman, J. Voltage-gated sodium channel blockers; target validation and therapeutic potential. Curr. Top. Med. Chem., 2005, 5, 529-537.
11. Xiao, Y.C.; Luo, X.; Kuang, F.; Deng, M.C.; Wang, M.C.; Zeng, X.Z.; Liang, S.P. Synthesis and characterization of huwentoxin-IV, a neurotoxin inhibiting central neuronal sodium channels. Toxicon, 2008, 51, 230-239.
12. Liu, Y.; Li, D.; Wu, Z.; Li, J.; Nie, D.S.; Xiang, Y.; Liu, Z.H. A positively charged surface patch is important for hainantoxin-IV binding to voltage-gated sodium channels. J. Pept. Sci., 2012, 18, 643-649.
13. Dubission, D.; Dennis, S.G. The formalin tests: a quantitative study of the analgesic effects of morphine, meperidine and brain stem stimulation in rats and cats. Pain, 1977, 4, 161-174.
14. Malmberg, A.B.; Yaksh, T.L. Effect of continuous intrathecal infusion of u-conopeptides, N-type calcium channel blockers, on behavior and antinociception in the formalin and hot-plate tests in rats. Pain, 1995, 60, 83-90.
15. Owoyele, V.B.; Oloriegbe, Y.Y.; Balogun, E.A.; Soladoye, A.O. Analgesic and anti-inflammatory properties of Nelsonia canescens leaf extract. J. Ethnopharmacol., 2005, 99, 153-156.
16. Collier, H.O.J.; Dinneen, J.C.; Johnson, C.A.; Schneider, C. The abdominal constriction response and its suppression by analgesic drugs in the mouse. Br. J Pharmacol. Chemother., 1968, 32, 295-310.
17. Decosterd, I.; Woolf, C.J. Spared nerve injury: an animal model for persistent peripheral neuropathic pain. Pain, 2000, 87, 149-158.
18. Ferrira, S.H.; Vane, S.R. New aspects on the model of action of nonsteroid anti-inflammatory drugs. Annu. Rev. Pharmacol., 2005, 98, 267-273.
19. Perianayagam, J.B.; Sharma, S.K.; Joseph, A.; Christina, A.J. Evaluation of antipyretic and analgesic activity of Emblica offici-nalis Gaertn. J. Ethnopharmacol., 2004, 95, 83-85.
20. Hong, Y.; Abbott, F.V. Peripheral opioid modulation of pain and inflammation in the formalin test. Eur. J. Pharmacol., 1995, 277, 21-28.
21. Vinegar, R.; Truax, J.F.; Selph, J.L.; Johnston, P.R. In: Handbook of Experimental Pharmacology; Vane JR, Ferreira SH, Ed.; Springer: Verlag, Berlin, 1979; Vol. 50, pp. 209-222.
22. Kumazawa, T.; Mizumura, K.; Koda, H.; Fukusako, H. EP receptor subtypes implicated in the PGE2-induced sensitization of polymodal receptors in response to bradykinin and heat. J. Neurophysiol., 1996, 75, 2361-2368.
23. Correa, C.R.; Kyle, D.J.; Chakraverty, S.; Calixto, J.B. Antinoci-ceptive profile of the pseudopeptide B2 bradykinin receptor antagonist NPC 18688 in mice. Br. J. Pharmacol., 1996, 117, 552-558.
24. Goettl, V.M.; Larson, A.A. An antagonist of substance P N-terminal fragments, D-substance P(1-7), reveals that both nocicep-tive and antinociceptive effects are induced by substance P N-terminal activity during noxious chemical stimulation. Br. Res., 1998, 780, 80-85.
25. Moncada, S.; Ferreira, S.H.; Vane, J.R. Inhibition of prostaglandin biosynthesis as the mechanism of analgesia of aspirin-like drugs in the dog knee joint. Eur. J. Pharmacol., 1975, 31, 250-260.
26. Bennett, G.J.; Xie, Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain, 1988, 33, 87-107.
27. Kim, S.H.; Chung, J.M. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain, 1992, 50, 355-363.
28. Erichsen, H.K.; Hao, J.X.; Xu, X.J.; Blackburn-Munro, G. A comparison of the antinociceptive effects of voltage-activated Na+ channel blockers in two rat models of neuropathic pain. Eur. J. Pharmacol., 2003, 458, 275-282.
29. Dib-Hajj, S.D.; Cummins, T.R.; Black, J.A.; Waxman, S.G. Sodium channels in normal and pathological pain. Annu. Rev. Neuro-sci., 2010, 33, 325-347.